Orlando, FL -- (SBWIRE) -- 11/01/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Inovio Pharmaceuticals Inc(NYSEMKT:INO), ShoreTel, Inc. (NASDAQ:SHOR), Bankrate Inc (NYSE:RATE).
Inovio Pharmaceuticals Inc(NYSEMKT:INO) shares decreased 3.35% to $1.73 in yesterday’s session. The company on Oct. 21 announced that the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in a phase I clinical trial in chronically HCV infected patients. Under a 2011 collaborative development agreement, Inovio's affiliate, VGX International Inc. (KSE:011000), is fully funding and conducting the study at multiple sites in Korea. Inovio is also planning to evaluate this hepatitis C (HCV) vaccine in additional clinical studies in the U.S. beginning in 2014.
Are investors worried about the recent updates with INO? Find out with a free trend analysis HERE
ShoreTel, Inc. (NASDAQ:SHOR) shares climbed 29.79% to $7.93. The company on Oct. 30 announced financial results for the first quarter of its fiscal year 2014, which ended September 30, 2013. For the first quarter of fiscal 2014, total revenue was $84.3 million, an increase of 12 percent compared to the first quarter of fiscal 2013. Non-GAAP net income for the first quarter of fiscal year 2014 was $4.0 million, or $0.07 per share. This compares with a non-GAAP net loss of $2.1 million, or $0.04 per share, in the first quarter of fiscal 2013. GAAP net loss was $1.0 million, or $0.02 per share, in the first quarter of fiscal 2014, compared with a GAAP net loss of $8.0 million, or $0.14 per share, in the first quarter of fiscal 2013.
Is SHOR going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Bankrate Inc (NYSE:RATE) shares fell 19.58% to $16.84. The company on Oct. 30 reported financial results for the third quarter ended September 30, 2013. Total revenue for the third quarter was $121.2 million compared to $116.8 million in the third quarter of 2012, an increase of 4%. Net loss for the quarter was $7.8 million or approximately $0.08 per fully diluted share, compared to net income of $2.6 million, or $0.03 per fully diluted share in the third quarter of 2012. Adjusted EPS were $0.13 for the third quarter of 2013, which is consistent with the third quarter of 2012.
Is RATE going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)